Overview of Dr. Drake
Dr. Charles Drake is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Colorado School of Medicine and has been in practice 20 years. Dr. Drake accepts several types of health insurance, listed below. He is one of 374 doctors at New York-Presbyterian Hospital and one of 119 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1999 - 2002- Johns Hopkins UniversityResidency, Internal Medicine, 1997 - 1999
University of Colorado School of Medicine Anschutz Medical CampusClass of 1997
Certifications & Licensure
NY State Medical License 2016 - 2026
MD State Medical License 2002 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
Clinical Trials
- Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2008 Jul 01
- Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy Start of enrollment: 2015 Mar 28
- Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) Start of enrollment: 2018 Oct 11
Publications & Presentations
PubMed
- Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer.Lisa N Chesner, Fanny Polesso, Julie N Graff, Jessica E Hawley, Alexis K Smith
Cancer Discovery. 2024-12-05 - Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.Matthew C Dallos, Aleksandar Z Obradovic, Patrick McCann, Nivedita Chowdhury, Aditya Pratapa
Clinical Cancer Research. 2024-11-15 - Neoadjuvant androgen deprivation therapy with or without Fc-enhanced non-fucosylated anti-CTLA-4 (BMS-986218) in high risk localized prostate cancer: a randomized phas...Casey R Ager, Aleksandar Obradovic, Patrick McCann, Matthew Chaimowitz, Alexander L E Wang
Medrxiv. 2024-09-11
Journal Articles
- A Role for Paracrine Interleukin‐6 Signaling in the Tumor Microenvironment in Prostate Tumor GrowthCharles Drake, MD, The Prostate
- And Inflammation in Prostate Cancer InitiationCharles Drake, MD, Development
- Expression of LAG‐3 and Efficacy of Combination Treatment with Anti‐LAG‐3 and Anti‐PD‐1 Monoclonal Antibodies in GlioblastomaCharles Drake, MD, International Journal of Cancer
- Join now to see all
Abstracts/Posters
- Checkpoint Inhibitor PD-1H/VISTA Functions As MMP-13 Receptor on Osteoclasts and Mediates MMP-13 Induced Osteoclast Activation in Multiple MyelomaCharles G Drake, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Safety and preliminary immunogenicity of JNJ-64041809, a live attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant...2019 ASCO Annual Meeting - 6/1/2019
- PD-L1: Prognostic and Predictive State of the Science2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Relationship between sipuleucel-T (sip-T) cytolytic T lymphocyte (CTL) activity and overall survival (OS) in patients (pts) with metastatic castration resistant prosta...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
News & PublicationsMay 1st, 2024- ASCO21 Preview - Equity: Every Patient. Every Day. EverywhereMay 27th, 2021
- VP&S Names 2021 Gerstner ScholarsApril 5th, 2021
- Join now to see all
Grant Support
- Role Of Tc17 Cells In Tumor ImmunotherapyNational Cancer Institute2012
- Blockade Of The Immune Checkpoint Mediated By B7-H1 In Men With Prostate CancerNational Cancer Institute2008–2011
- Analysis Of LAG-3 In Regulatory T Cell Function And Immune SupressionNational Cancer Institute2008–2011
- Regulation Of The Immune Response To Prostate CancerNational Cancer Institute2003–2007
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/charles-drake
Insurance Accepted
- BCBS Blue Card PPO
CareFirst BCBS Maryland POS
CareFirst BlueChoice Advantage
CareFirst BlueChoice Network POS
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
